Award
NIH Reporter #5R44AI177179-03
Multidimensional antibody engineering to enhance the potency and breadth of a betacoronavirus medical countermeasure
Recipient
EITR BIOLOGICS, INC.
Award Amount
$1,000,000.00
Ceiling
$1,000,000.00
Awarded
August 27, 2026
Identifier
5R44AI177179-03
Award for developing a bispecific antibody to enhance potency and breadth against betacoronaviruses, funded by NIAID.
Description
The project involves antibody engineering targeting betacoronaviruses, including SARS-CoV-2 and MERS. The project aims to develop a bispecific antibody to combat viral escape and antigenic drift. The project is supported by the National Institute of Allergy and Infectious Diseases (NIAID).